Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06627582 · ClinicalTrials.gov registry record · NA
A Study on Pain After Breast Reconstruction
A NA study of Breast Reconstruction and Mastectomy, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 7
- Study locations
NCT06627582: Recruiting NA study of Breast Reconstruction and Mastectomy, sponsored by Memorial Sloan Kettering Cancer Center.
NCT06627582 is a NA study of Breast Reconstruction and Mastectomy that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 500 participants, above the 366-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (37% higher). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06627582, a NA study of Breast Reconstruction and Mastectomy, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to find out how common persistent postmastectomy pain (PPMP) is among people who have had a mastectomy and breast reconstruction surgery for their breast cancer. The study will also look at how effective regenerative peripheral nerve interface (RPNI) surgery is for reducing pain from neuropathic PPMP after breast reconstruction.
Primary Outcome
The primary objective is to estimate the prevalence of Persistent Postmastectomy Pain/PPMP in breast cancer survivors treated with mastectomy and reconstruction.
Conditions Studied
Interventions
- BEHAVIORAL PROMIS Scale v2.0 - Pain Intensity 3a
- BEHAVIORAL PROMIS 29+2
- BEHAVIORAL PROMIS Scale v2.0 - Nociceptive Pain Quality 5a
- BEHAVIORAL PROMIS Scale v2.0 - Neuropathic Pain Quality 5a
Study Locations (7)
New York
- Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) - Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activites) - New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activites) - Rockville Centre
New Jersey
- Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities) - Basking Ridge
- Memoral Sloan Kettering Monmouth (Limited protocol activities) - Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2027-10-01 |
| Phase | NA |
What NCT06627582 shows while recruiting
NCT06627582 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 366-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (37% higher).
The record links to 6 conditions, with Breast Reconstruction appearing as the primary indexed condition, and to 4 interventions - of which PROMIS Scale v2.0 - Pain Intensity 3a is the first listed.
NCT06627582 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT06627582 about?
NCT06627582 is a clinical study titled "A Study on Pain After Breast Reconstruction". The purpose of this study is to find out how common persistent postmastectomy pain (PPMP) is among people who have had a mastectomy and breast reconstruction surgery for their breast cancer. The study will also look at how effective regenerative peripheral nerve interface (RPNI) surgery is for reduc...
What is the current status of trial NCT06627582?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2024-10-01. Estimated completion is 2027-10-01.
What conditions does trial NCT06627582 study?
This clinical trial studies the following conditions: Breast Reconstruction, Mastectomy, Mastectomy Patient, Mastectomy and Breast Reconstruction, Breast Reconstruction After Mastectomy.
What interventions are being tested in trial NCT06627582?
The interventions under investigation include: PROMIS Scale v2.0 - Pain Intensity 3a (BEHAVIORAL), PROMIS 29+2 (BEHAVIORAL), PROMIS Scale v2.0 - Nociceptive Pain Quality 5a (BEHAVIORAL), PROMIS Scale v2.0 - Neuropathic Pain Quality 5a (BEHAVIORAL).
Who is sponsoring clinical trial NCT06627582?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06627582 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Reconstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06627582's enrollment target sits among peer trials
500 5th of 18 higher than 14 of 18 other Breast Reconstruction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Reconstruction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Melodi Matrix™ in Breast Reconstruction
RECRUITING · NA
-
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
RECRUITING · NA
-
Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction
RECRUITING · NA
-
Pulsed Lavage in Implant-Based Breast Reconstruction
RECRUITING · NA
-
SAVE Trial: SAfe Opioid Use Video Education
RECRUITING · NA
-
Acellular Dermal Matrix Investigation in Breast Reconstruction
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI